324 related articles for article (PubMed ID: 15035437)
1. [Slow progress in therapy of breast carcinoma].
Aumiller J
MMW Fortschr Med; 2004 Jan; 146(3-4):4-6, 8, 10. PubMed ID: 15035437
[No Abstract] [Full Text] [Related]
2. [Organ preserving treatment of breast cancer].
Topuzov EG; Krasnozhon DA
Vestn Khir Im I I Grek; 2004; 163(3):99-102. PubMed ID: 15317177
[No Abstract] [Full Text] [Related]
3. [Current trends in the treatment of primary breast cancer].
Letiagin VP
Vopr Onkol; 1998; 44(5):632-5. PubMed ID: 9884732
[No Abstract] [Full Text] [Related]
4. [Current status and perspective in treatment of breast cancer in elderly women].
Zhang BN; Zhang HM
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):161-4. PubMed ID: 18756927
[No Abstract] [Full Text] [Related]
5. Breast cancer (non-metastatic).
Rodger A; Stebbing J; Thompson AM
Clin Evid; 2006 Jun; (15):2360-92. PubMed ID: 16973090
[No Abstract] [Full Text] [Related]
6. Treatment of breast cancer.
Zurrida S; Veronesi U
Ann Chir Gynaecol; 2000; 89(3):187-90. PubMed ID: 11079786
[No Abstract] [Full Text] [Related]
7. Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors.
Singh Ranger G
J Clin Pharm Ther; 2005 Aug; 30(4):313-7. PubMed ID: 15985044
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant use of endocrine therapy in breast cancer.
Macaskill EJ; Dixon JM
Breast J; 2007; 13(3):243-50. PubMed ID: 17461898
[TBL] [Abstract][Full Text] [Related]
9. [Breast carcinoma in accessory gland: a case report].
Sivelli R; Del Rio P; Arcuri MF; Corcione L
G Chir; 2002 May; 23(5):179-80. PubMed ID: 12228967
[TBL] [Abstract][Full Text] [Related]
10. What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.
Koc M
J Clin Oncol; 2007 Dec; 25(36):5841; author reply 5844-5. PubMed ID: 18089889
[No Abstract] [Full Text] [Related]
11. Ductal carcinoma in situ--current management.
O'Sullivan MJ; Morrow M
Surg Clin North Am; 2007 Apr; 87(2):333-51, viii. PubMed ID: 17498530
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibitors in adjuvant therapy of breast cancer: before, instead of, or beyond tamoxifen.
Pritchard KI
J Clin Oncol; 2005 Aug; 23(22):4850-2. PubMed ID: 16009956
[No Abstract] [Full Text] [Related]
13. Breast-conserving therapy (BCT) for early-stage breast cancer.
Benda RK; Mendenhall NP; Lind DS; Cendan JC; Shea BF; Richardson LC; Copeland EM
J Surg Oncol; 2004 Jan; 85(1):14-27. PubMed ID: 14696083
[TBL] [Abstract][Full Text] [Related]
14. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study.
Martelli G; Miceli R; Costa A; Coradini D; Zurrida S; Piromalli D; Vetrella G; Greco M
Cancer; 2008 Feb; 112(3):481-8. PubMed ID: 18098268
[TBL] [Abstract][Full Text] [Related]
15. Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?
Van Poznak CH; Hayes DF
J Natl Cancer Inst; 2006 Sep; 98(18):1261-3. PubMed ID: 16985239
[No Abstract] [Full Text] [Related]
16. [Current standards in the treatment of breast cancer].
Zwiefel K; Janni W
Med Monatsschr Pharm; 2011 Aug; 34(8):280-88; quiz 289-90. PubMed ID: 21853882
[TBL] [Abstract][Full Text] [Related]
17. [For postmenopausal women with hormone-dependent tumors. Aromatase inhibitors are the new gold standard].
Jonat W
MMW Fortschr Med; 2006 Mar; 148(12):10. PubMed ID: 16625996
[No Abstract] [Full Text] [Related]
18. Ductal carcinoma-in-situ.
Wickerham DL
J Clin Oncol; 2001 Sep; 19(18 Suppl):98S-100S. PubMed ID: 11560982
[No Abstract] [Full Text] [Related]
19. [Breast neoplasms: predictive factors for endocrine therapy ].
Hayashi S
Nihon Rinsho; 2007 Jun; 65 Suppl 6():148-53. PubMed ID: 17682151
[No Abstract] [Full Text] [Related]
20. Aromatase inhibitors in breast cancer: an overview.
Altundag K; Ibrahim NK
Oncologist; 2006 Jun; 11(6):553-62. PubMed ID: 16794235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
